Prof Robert Forbes from the School of Pharmacy and Biomedical Science is UCLan’s Principal Investigator for a recently launched £1M+ Innovate UK Collaborative R& D grant project
“Towards a condensed screening platform for aggregation profiling”
Biotherapeutic drugs are an increasingly important class of new medicines and their effective action in the therapeutic treatment of disease has attracted interest from both academic and industry sectors. Despite the overwhelming benefits to patients, the availability of these drugs at point-of-care is inextricably linked to their affordability. This project brings together biopharmaceutical companies including CPI, academic research leaders (Prof RT Forbes, UClan) and developers of scientific instruments (Malvern Instruments Ltd, Paraytec Ltd.) in order to produce novel sensors that can improve the detection of nano-sized drug aggregates throughout the drug development process. With this novel analytical technology, we aim to attenuate the risks associated with aggregation to ensure the delivery of safe and cost-effective drugs in the future.